Zhiqiang Sun
Key Laboratory Of Energy Plants Resource And Utilization
Guangzhou, 510642, China
Guangzhou, 510642, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Hydrogels as an emerging engineering platform for immobilizing cells or enzymes.
Journal: Journal of materials chemistry. B
Published: June 25, 2026
Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study.
Journal: Experimental hematology & oncology
Published: March 25, 2026
Soluble Lignin as a Multifunctional Enhancer in Microbial Fermentation.
Journal: Journal of agricultural and food chemistry
Published: December 12, 2025
Chinese guidelines on comprehensive assessment of clinical practice in hematopoietic stem cell transplantation Δ.
Journal: Journal of cancer research and therapeutics
Published: December 02, 2025
Discovery of PD-L1 inhibitors featuring novel indole and pyrrolopyridine scaffolds with PD-L1 degradation activity in vivo.
Journal: Bioorganic chemistry
Published: November 27, 2025
Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study.
Journal: Annals of hematology
Published: September 09, 2025
Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy.
Journal: Signal transduction and targeted therapy
Published: June 12, 2025
Targeted NAT10 Degradation by PROTAC NP1192 Suppresses Hypoxia-Adaptive Glycolysis and Reinvigorates CD8+ Effector T‑Cell Function for Synergistic Cancer Immunotherapy.
Journal: ACS central science
Published: May 06, 2025
Successful treatment of transplant-associated thrombotic microangiopathy with iptacopan: a non-adult case study.
Journal: Frontiers in immunology
Published: February 26, 2025
Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy.
Journal: Journal of medicinal chemistry
Published: January 23, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.
Journal: Leukemia
Published: January 20, 2025
Last Updated: 09/26/2026